Effect of Allopurinol Supplementation on Nitric Oxide Levels in Asphyxiated Newborns

Pediatric Neurology

Volumn 36, Issue 1, 2007, Pages 17-24

  Gunes, Tamer ^a   Ozturk, Mehmet Adnan ^a   Koklu, Esad ^a   Kose, Kader ^a   Gunes, Isin ^a,b  

^a ERCIYES UNIVERSITY   (Turkey)

^b Department of Anesthesiology and Reanimation ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; NITRIC OXIDE; PLACEBO; SCAVENGER;

ARTICLE; BLOOD LEVEL; BRAIN ISCHEMIA; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; ERYTHEMA; FEMALE; HUMAN; LEUKOCYTE COUNT; MACULOPAPULAR RASH; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGICAL COMPLICATION; NEWBORN; PATIENT MONITORING; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; BLOOD; BRAIN HYPOXIA; CEREBROSPINAL FLUID; CHILD DEVELOPMENT; INFANT; METABOLISM; NEWBORN HYPOXIA;

ALLOPURINOL; ASPHYXIA NEONATORUM; CHILD DEVELOPMENT; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; HYPOXIA, BRAIN; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE; PLACEBOS; TREATMENT OUTCOME;

EID: 33947331502     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2006.08.005     Document Type: Article

References (38)

1. Vannucci R.C. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics 85 (1995) 961-968
2. Moorhouse P.C., and Grootveld M. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 213 (1987) 23-28
3. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20 (1997) 132-139
4. Du Plessis A.J., and Johnson V.M. Hypoxic-ischemic brain injury in the newborn: Cellular mechanisms and potential strategies for neuroprotection. Clin Perinatol 24 (1997) 627-657
5. Moskowitz A.M., and Dalkara T. Nitric oxide and cerebral ischemia. In: Siesjo B.K., and Tadeusz W. (Eds). Cellular and molecular mechanics of ischemic brain damage (1996), Lippincott-Raven, Philadelphia 365-369
6. Ergenekon E., Gucuyener K., Erbas D., Suheyl Ezgu F., and Atalay Y. Cerebrospinal fluid and serum nitric oxide levels in asphyxiated newborns. Biol Neonate 76 (1999) 200-206
7. Buisson A., Plotkine M., and Boulu R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol 106 (1992) 706-767
8. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87 (1990) 682-685
9. Mechurova A., Stipek S., Novak L., and Trojan S. The hypoxanthine level in cord blood-a potential indicator of foetal hypoxia. Physiol Bohemoslov 34 (1985) 173-176
10. Gucuyener K., Ergenekon E., Demiryurek T., et al. Cerebrospinal fluid levels of nitric oxide and nitrotyrosine in neonates with mild hypoxic-ischemic encephalopathy. J Child Neurol 17 (2002) 815-818
11. Fukahori M., Ichimori K., Ishida H., Nakagawa H., and Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radic Res 21 (1994) 203-212
12. Terada L.S., Piermattei D., Shibao G.N., McManaman J.L., and Wright R.M. Hypoxia regulates xanthine dehydrogenase activity at pre- and posttranslational levels. Arch Biochem Biophys 348 (1997) 163-168
13. Millar T.M., Stevens C.R., Benjamin N., Eisenthal R., Harrison R., and Blake D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 427 (1998) 225-228
14. Trujillo M., Alvarez M.N., Peluffo G., Freeman B.A., and Radi R. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J Biol Chem 273 (1998) 7828-7834
15. Ungvari Z., Gupte S.A., Recchia F.A., Batkai S., and Pacher P. Role of oxidativenitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vas Pharmacol 3 (2005) 221-229
16. Pacher P., Obrosova I.G., Mabley J.G., and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications: Emerging new therapeutical strategies. Curr Med Chem 12 (2005) 267-275
17. Tollner U. Early diagnosis of septicaemia in the newborn: Clinical studies and sepsis score. Eur J Pediatr 138 (1982) 331-337
18. Alistair G.S., Phillip A.G.S., and Hewitt J.R. Early diagnosis of neonatal sepsis. Pediatrics 65 (1980) 1036-1041
19. Manroe B.L., Weinberg A.G., Rosenfeld C.R., and Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95 (1979) 89-98
20. Sarnat H.B., and Sarnat M.S. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 33 (1976) 696-705
21. Dalkara T., and Moskowitz A.M. Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischemia: Neuroprotective agents and cerebral ischemia (1997), Academic Press, New York 319-336
22. Lawson L.J., Perry V.H., Dri P., and Gordon S. Heterogeneity in the normal and adult mouse brain. Neuroscience 39 (1990) 151-170
23. Palmer C., Vannucci R.C., and Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 27 (1990) 332-336
24. Phillis J.W., and Lin Y. Oxypurinol reduces ischemic brain injury in the gerbil and rat. Adv Exp Med Biol 309A (1991) 343-346
25. Palmer C., Smith M.B., and Williams G.D. Allopurinol preserves cerebral energy metabolism during perinatal hypoxic-ischemic injury and reduces brain damage in a dose dependent manner. J Cereb Blood Flow Metab 11 (1991) S144-S149
26. Ko K.M., and Godin D.V. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 40 (1990) 803-809
27. Marro P., McGowan J., Razdan B., Mishra O., and Delivoria-Papadopoulos M. Effect of allopurinol on uric acid levels and brain cell membrane Na+, K+-ATPase activity during hypoxia in newborn piglets. Brain Res 650 (1994) 9-15
28. Shadid M., Moison R., Steendijk P., Hiltermann L., Berger H.M., and van Bel F. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr Res 44 (1998) 119-124
29. Whitelaw A. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin Neonatol 5 (2000) 33-40
30. Van Bel F., Shadid M., Moison R.M., et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 101 (1998) 185-193
31. Marro P.J., Hoffman D., Schneiderman R., Mishra O.P., and Delivoria-Papadopoulos M. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 787 (1998) 71-77
32. Palmer C., Vannucci R.C., and Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 27 (1990) 332-336
33. Benders M.J., Bos A.F., Rademaker C.M., et al. Early postnatal allopurinol does not improve short-term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed (2006) Jan 20 [Epub ahead of print].
34. Kornelisse R.F., Hoekman K., Visser J.J., et al. The role of nitric oxide in bacterial meningitis in children. J Infect Dis 174 (1996) 120-126
35. Shi Y., Li H.Q., Shen C.K., et al. Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 123 (1993) 435-438
36. Endo A., Shimada M., Ayusawa M., Minato M., Takada M., and Takahashi S. Nitric oxide and endothelin-1 during postnatal life. Biol Neonate 70 (1996) 15-20
37. Giovannoni G. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis. Mult Scler 4 (1998) 27-30
38. Volpe J.J. Hypoxic-ischemic encephalopathy: Biochemical and physiological aspects. Neurology of the newborn. 4th ed. (2001), Saunders, Philadelphia 221-239 331-63.